Literature DB >> 15256582

rexAB mutants in Streptococcus pneumoniae.

David Halpern1, Alexandra Gruss1, Jean-Pierre Claverys2, Meriem El Karoui1.   

Abstract

Streptococcus pneumoniae is a human pathogen that is naturally transformable. In this study a major component of the homologous recombination pathway, the RexAB exonuclease/helicase, was characterized. rexA and rexB insertional mutants were constructed using mariner mutagenesis and found to have identical phenotypes. Both rexAB mutants displayed poor cell viability, reduced double-strand exonuclease activity, UV sensitivity and a reduced level of gene conversion compared to the wild-type strain. No effect was observed on plasmid and chromosomal transformation efficiencies. These results indicate that in S. pneumoniae, RexAB is required for DNA repair, but not for chromosomal transformation and plasmid establishment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256582     DOI: 10.1099/mic.0.27106-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  13 in total

Review 1.  RecBCD enzyme and the repair of double-stranded DNA breaks.

Authors:  Mark S Dillingham; Stephen C Kowalczykowski
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

2.  Phylogenetic ubiquity and shuffling of the bacterial RecBCD and AddAB recombination complexes.

Authors:  Gareth A Cromie
Journal:  J Bacteriol       Date:  2009-06-19       Impact factor: 3.490

3.  Structure-function analysis of pneumococcal DprA protein reveals that dimerization is crucial for loading RecA recombinase onto DNA during transformation.

Authors:  Sophie Quevillon-Cheruel; Nathalie Campo; Nicolas Mirouze; Isabelle Mortier-Barrière; Mark A Brooks; Marion Boudes; Dominique Durand; Anne-Lise Soulet; Johnny Lisboa; Philippe Noirot; Bernard Martin; Herman van Tilbeurgh; Marie-Françoise Noirot-Gros; Jean-Pierre Claverys; Patrice Polard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

Review 4.  The cell pole: the site of cross talk between the DNA uptake and genetic recombination machinery.

Authors:  Dawit Kidane; Silvia Ayora; Joann B Sweasy; Peter L Graumann; Juan C Alonso
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-10-09       Impact factor: 8.250

5.  Comparative and evolutionary analysis of the bacterial homologous recombination systems.

Authors:  Eduardo P C Rocha; Emmanuel Cornet; Bénédicte Michel
Journal:  PLoS Genet       Date:  2005-08-26       Impact factor: 5.917

6.  Unveiling novel RecO distant orthologues involved in homologous recombination.

Authors:  Stéphanie Marsin; Aurélie Mathieu; Thierry Kortulewski; Raphaël Guérois; J Pablo Radicella
Journal:  PLoS Genet       Date:  2008-08-01       Impact factor: 5.917

7.  RecFOR is not required for pneumococcal transformation but together with XerS for resolution of chromosome dimers frequently formed in the process.

Authors:  Calum Johnston; Isabelle Mortier-Barrière; Chantal Granadel; Patrice Polard; Bernard Martin; Jean-Pierre Claverys
Journal:  PLoS Genet       Date:  2015-01-08       Impact factor: 5.917

8.  Absence of tmRNA Has a Protective Effect against Fluoroquinolones in Streptococcus pneumoniae.

Authors:  Liliana Brito; Joana Wilton; María J Ferrándiz; Alicia Gómez-Sanz; Adela G de la Campa; Mónica Amblar
Journal:  Front Microbiol       Date:  2017-01-10       Impact factor: 5.640

9.  Generation of Markerless Deletions in the Nosocomial Pathogen Clostridium difficile by Induction of DNA Double-Strand Breaks.

Authors:  Elena-Stella Theophilou; Prerna Vohra; Maurice P Gallagher; Ian R Poxton; Garry W Blakely
Journal:  Appl Environ Microbiol       Date:  2019-01-23       Impact factor: 4.792

Review 10.  End-resection at DNA double-strand breaks in the three domains of life.

Authors:  John K Blackwood; Neil J Rzechorzek; Sian M Bray; Joseph D Maman; Luca Pellegrini; Nicholas P Robinson
Journal:  Biochem Soc Trans       Date:  2013-02-01       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.